Cell Line Development (CLD)
Proprietary platform to derive high-producing CHO host cell lines and stable clones tailored to your molecule.
Learn More →We design high-performance CHO host cell lines, matched media & feeds and scalable upstream/downstream processes — fast, reliable, and GMP-ready.
Proprietary platform to derive high-producing CHO host cell lines and stable clones tailored to your molecule.
Learn More →Bioreactor process design and scale-up guidance that preserves product quality and increases titer.
Learn More →Integrated purification workflows with in-line analytics and robust CQA control.
Learn More →Custom analytical methods for potency, purity and stability to support regulatory filings.
Learn More →Proprietary formulations engineered to maximize productivity while preserving product quality. Optimized for CHO cell cultures with enhanced nutrient delivery and reduced metabolic waste.
Explore FormulationsAdapted CHO host lines optimized for biosimilar manufacturing and rapid tech transfer. Pre-validated for high productivity and stability in various production systems.
View Cell LinesVisit us at booth 20C11 to discover our latest platform improvements and meet our scientific team.
Achievement of ISO 9001:2015 — reinforcing our processes and quality management across operations.
Fonix Pharma contributes to research programs and partnerships focused on rare disease therapies.
Fonix Pharma GmbH was established in 2009 in a key biotech location. We specialize in the development of monoclonal cell lines for the production of advanced biologics and biosimilars.
Using our platform, we deliver robust processes — from cell line development to GMP-ready manufacturing support — with an emphasis on speed and cost-effectiveness.
Read More